Home

Robert Altman, MD, FRCPC

Academic title(s): 

Assistant Professor
MD, FRCPC, CSCN Diplomate (EMG), BSc Physical Therapy

Robert Altman, MD, FRCPC
Contact Information
Phone: 
514-340-8060
Fax number: 
514-340-7567
Email address: 
robertdaniel.altman [at] mcgill.ca
Division: 
Neurology
Location: 
Jewish General Hospital
Biography: 

Dr. Altman's clinical interests include:

  • Education - Teaching in neurology with a strong emphasis on clinical reasoning. Medical school, residency and post-graduate level.
  • Advanced general neurology - neurological complications of systemic diseases, including:
    • Sarcoidosis
    • Neuro-infectious diseases
    • Neuro-toxicology
    • Neuro-oncology
    • Vasculitis
    • Complications of rheumatic diseases
    • Paraneoplastic syndromes
  • Electromyography
  • Nerve and muscle diseases
  • Headache / craniofacial pain / migraine disorders:
    • Greater / lesser occipital nerve blocks.
  • Movement disorders
  • Parkinson's disease, essential tremor
  • Multiple sclerosis and other neuro-inflammatory disorders
Selected publications: 

1: Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012 Aug 14;79(7):651-8. PubMed PMID: 22855866; PubMed Central PMCID: PMC3414662.

2: Romenets SR, Wolfson C, Galatas C, Pelletier A, Altman R, Wadup L, Postuma RB. Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism

Relat Disord. 2012 Jan;18(1):54-8. PubMed PMID: 21917501.

3: Altman RD, Lang AE, Postuma RB. Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study. Mov Disord. 2011 Nov;26(13):2427-31. PubMed PMID: 21953603.

Back to top